Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea
· Delayed Price · Currency is KRW
16,350
-1,530 (-8.56%)
At close: Dec 5, 2025
KOSDAQ:014950 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | 3,522 | 2,969 |
| Depreciation & Amortization | 1,351 | 1,278 |
| Loss (Gain) From Sale of Assets | -9.5 | -0.07 |
| Asset Writedown & Restructuring Costs | 23.8 | - |
| Loss (Gain) From Sale of Investments | -300.14 | -298.32 |
| Stock-Based Compensation | 263.58 | 72.69 |
| Provision & Write-off of Bad Debts | -2.68 | -65.12 |
| Other Operating Activities | 1,391 | 696.68 |
| Change in Accounts Receivable | 558.63 | -1,117 |
| Change in Inventory | -2,105 | -55.64 |
| Change in Accounts Payable | 251.69 | -827.43 |
| Change in Income Taxes | - | -3.98 |
| Change in Other Net Operating Assets | -559.9 | -400.44 |
| Operating Cash Flow | 4,385 | 2,248 |
| Operating Cash Flow Growth | 95.04% | - |
| Capital Expenditures | -842.32 | -1,374 |
| Sale (Purchase) of Intangibles | -5.83 | -3.14 |
| Investment in Securities | -1,613 | -120.5 |
| Other Investing Activities | - | -70 |
| Investing Cash Flow | -2,161 | -1,868 |
| Long-Term Debt Repaid | -137.56 | -109.02 |
| Net Debt Issued (Repaid) | -137.56 | -109.02 |
| Issuance of Common Stock | 672.3 | - |
| Dividends Paid | -281 | -140.5 |
| Other Financing Activities | -1.02 | - |
| Financing Cash Flow | 252.72 | -249.52 |
| Miscellaneous Cash Flow Adjustments | - | -0 |
| Net Cash Flow | 2,477 | 130.88 |
| Free Cash Flow | 3,543 | 874.05 |
| Free Cash Flow Growth | 305.32% | - |
| Free Cash Flow Margin | 6.34% | 1.71% |
| Free Cash Flow Per Share | 503.91 | 124.52 |
| Cash Interest Paid | 12.04 | 18.36 |
| Cash Income Tax Paid | 205.69 | 3.03 |
| Levered Free Cash Flow | 3,382 | - |
| Unlevered Free Cash Flow | 3,389 | - |
| Change in Working Capital | -1,854 | -2,405 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.